BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 17045042)

  • 1. [The changes and clinical implications of serum procalcitonin in acute exacerbations of chronic obstructive pulmonary disease].
    Chang C; Yao WZ; Chen YH; Liu ZY; Zhang XW
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Jul; 29(7):444-7. PubMed ID: 17045042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Value of serum procalcitonin in diagnosing bacterial lower respiratory tract infections in people with exacerbation of Chronic Obstructive Pulmonary Disease].
    Chang C; Yao WZ; Chen YH; Liu ZY; Zhang XW
    Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Aug; 38(4):389-92. PubMed ID: 16892144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procalcitonin levels in acute exacerbation of COPD admitted in ICU: a prospective cohort study.
    Daubin C; Parienti JJ; Vabret A; Ramakers M; Fradin S; Terzi N; Freymuth F; Charbonneau P; du Cheyron D
    BMC Infect Dis; 2008 Oct; 8():145. PubMed ID: 18947382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procalcitonin and C-reactive protein cannot differentiate bacterial or viral infection in COPD exacerbation requiring emergency department visits.
    Chang CH; Tsao KC; Hu HC; Huang CC; Kao KC; Chen NH; Yang CT; Tsai YH; Hsieh MJ
    Int J Chron Obstruct Pulmon Dis; 2015; 10():767-74. PubMed ID: 25926728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of diagnostic values of procalcitonin, C-reactive protein and blood neutrophil/lymphocyte ratio levels in predicting bacterial infection in hospitalized patients with acute exacerbations of COPD.
    Tanrıverdi H; Örnek T; Erboy F; Altınsoy B; Uygur F; Atalay F; Tor MM
    Wien Klin Wochenschr; 2015 Oct; 127(19-20):756-63. PubMed ID: 25586444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors predicting bacterial involvement in severe acute exacerbations of chronic obstructive pulmonary disease.
    Nseir S; Cavestri B; Di Pompeo C; Diarra M; Brisson H; Lemyze M; Roussel-Delvallez M; Durocher A
    Respiration; 2008; 76(3):253-60. PubMed ID: 18547944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of procalcitonin, C-reactive protein, and neopterin in exacerbations of chronic obstructive pulmonary disease.
    Lacoma A; Prat C; Andreo F; Lores L; Ruiz-Manzano J; Ausina V; Domínguez J
    Int J Chron Obstruct Pulmon Dis; 2011; 6():157-69. PubMed ID: 21468168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of fractional exhaled nitric oxide combined with serum procalcitonin and C-reactive protein in evaluation of elderly asthma.
    Wu JZ; Ma LJ; Zhao LM; Zhang XY; Chen XL; Kuang HY
    J Huazhong Univ Sci Technolog Med Sci; 2013 Apr; 33(2):185-188. PubMed ID: 23592127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy.
    Stolz D; Christ-Crain M; Bingisser R; Leuppi J; Miedinger D; Müller C; Huber P; Müller B; Tamm M
    Chest; 2007 Jan; 131(1):9-19. PubMed ID: 17218551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procalcitonin levels and bacterial aetiology among COPD patients admitted to the ICU with severe pneumonia: a prospective cohort study.
    Daubin C; Parienti JJ; Fradin S; Vabret A; Ramakers M; Terzi N; Freymuth F; Charbonneau P; du Cheyron D
    BMC Infect Dis; 2009 Sep; 9():157. PubMed ID: 19772586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.
    Christ-Crain M; Jaccard-Stolz D; Bingisser R; Gencay MM; Huber PR; Tamm M; Müller B
    Lancet; 2004 Feb; 363(9409):600-7. PubMed ID: 14987884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: a randomized noninferiority trial.
    Verduri A; Luppi F; D'Amico R; Balduzzi S; Vicini R; Liverani A; Ruggieri V; Plebani M; Barbaro MP; Spanevello A; Canonica GW; Papi A; Fabbri LM; Beghè B;
    PLoS One; 2015; 10(3):e0118241. PubMed ID: 25760346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sputum purulence-guided antibiotic use in hospitalised patients with exacerbations of COPD.
    Soler N; Esperatti M; Ewig S; Huerta A; Agustí C; Torres A
    Eur Respir J; 2012 Dec; 40(6):1344-53. PubMed ID: 22523352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procalcitonin vs C-reactive protein as predictive markers of response to antibiotic therapy in acute exacerbations of COPD.
    Daniels JM; Schoorl M; Snijders D; Knol DL; Lutter R; Jansen HM; Boersma WG
    Chest; 2010 Nov; 138(5):1108-15. PubMed ID: 20576731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Procalcitonin as a Biomarker for the Prediction of Bacterial Exacerbation and Mortality in Severe COPD Exacerbations Requiring Mechanical Ventilation.
    Ergan B; Şahin AA; Topeli A
    Respiration; 2016; 91(4):316-24. PubMed ID: 27081845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procalcitonin as a prognostic factor in severe acute exacerbation of chronic obstructive pulmonary disease.
    Rammaert B; Verdier N; Cavestri B; Nseir S
    Respirology; 2009 Sep; 14(7):969-74. PubMed ID: 19659517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of steroids on procalcitonin and C-reactive protein in patients with COPD and community-acquired pneumonia.
    Perren A; Cerutti B; Lepori M; Senn V; Capelli B; Duchini F; Domenighetti G
    Infection; 2008 Mar; 36(2):163-6. PubMed ID: 18330505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute exacerbations of chronic obstructive pulmonary disease with low serum procalcitonin values do not benefit from antibiotic treatment: a prospective randomized controlled trial.
    Wang JX; Zhang SM; Li XH; Zhang Y; Xu ZY; Cao B
    Int J Infect Dis; 2016 Jul; 48():40-5. PubMed ID: 27155210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum procalcitonin levels in chronic obstructive pulmonary disease patients in North Indian Population.
    Pandey S; Garg R; Kant S; Verma A; Gaur P
    Ann Afr Med; 2019; 18(2):103-107. PubMed ID: 31070153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of serum procalcitonin values in patients with acute exacerbations of chronic obstructive pulmonary disease: a cautionary note.
    Falsey AR; Becker KL; Swinburne AJ; Nylen ES; Snider RH; Formica MA; Hennessey PA; Criddle MM; Peterson DR; Walsh EE
    Int J Chron Obstruct Pulmon Dis; 2012; 7():127-35. PubMed ID: 22399852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.